There are three companies in phase 3 trials for Covid-19 vaccination. According to Dr. Faucci, the most likely time frame for their availability (if successful) to the wide masses is next summer to fall. It will be even longer to cover the rest of the world.

Thus, Todos is nicely positioned to increase market share and revenue regarding test kits and medical equipment supplies. Taking advantage of current situation, it is nice to hear they are shoring up their future core business in breast cancer detection (and hopefully including Lympro).